| Mrs Josephine A Adewumi, PA-C | |
|
294 Daniel Webster Hwy, Merrimack, NH 03054-4474 | |
| (603) 440-7722 | |
| Not Available |
| Full Name | Mrs Josephine A Adewumi |
|---|---|
| Gender | Female |
| Speciality | Physician Assistant |
| Experience | 19 Years |
| Location | 294 Daniel Webster Hwy, Merrimack, New Hampshire |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1942310024 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363AM0700X | Physician Assistant - Medical | 0557 (New Hampshire) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mary Hitchcock Memorial Hospital | 4486561164 | 964 |
News Archive
The use of chemotherapy before surgery to remove ovarian cancer has increased dramatically in recent decades, particularly among certain patients, according to a new analysis from Fox Chase Cancer Center that will be presented at the 50th Annual Meeting of the American Society of Clinical Oncology.
An app that allows parents and doctors to monitor a child's asthma has a big impact on managing the disease.
Idera Pharmaceuticals, Inc. announced today that it is presenting data on IMO-3100, an antagonist of TLR7 and TLR9, in a preclinical model of lupus showing that treatment with IMO-3100 suppressed several key disease progression parameters.
Researchers have developed an index scale to help physicians predict a patient's risk of dying from chronic obstructive pulmonary disease (COPD). The ADO index can help physicians assess the severity of a patient's illness to determine the appropriate level of treatment. COPD, which comprises emphysema and chronic bronchitis, is a major public health problem and it is the fourth leading cause of death in the U.S. The study of the ADO index is published in the August 29 edition of the Lancet.
Results from a new major diabetes eye health study may have the potential to change the way vision loss due to diabetic macular edema, a serious and devastating complication of diabetes, is treated. One year results from the RESTORE study show that 37 per cent of patients treated with ranibizumab only and 43 per cent of those treated with ranibizumab plus laser therapy, had a significant improvement in visual acuity of 10 letters or more on an eye chart, compared to 16 per cent of patients treated with laser alone - the current standard treatment for visual impairment due to DME.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Josephine A Adewumi, PA-C 294 Daniel Webster Hwy, Merrimack, NH 03054-4474 Ph: (603) 440-7722 | Mrs Josephine A Adewumi, PA-C 294 Daniel Webster Hwy, Merrimack, NH 03054-4474 Ph: (603) 440-7722 |
News Archive
The use of chemotherapy before surgery to remove ovarian cancer has increased dramatically in recent decades, particularly among certain patients, according to a new analysis from Fox Chase Cancer Center that will be presented at the 50th Annual Meeting of the American Society of Clinical Oncology.
An app that allows parents and doctors to monitor a child's asthma has a big impact on managing the disease.
Idera Pharmaceuticals, Inc. announced today that it is presenting data on IMO-3100, an antagonist of TLR7 and TLR9, in a preclinical model of lupus showing that treatment with IMO-3100 suppressed several key disease progression parameters.
Researchers have developed an index scale to help physicians predict a patient's risk of dying from chronic obstructive pulmonary disease (COPD). The ADO index can help physicians assess the severity of a patient's illness to determine the appropriate level of treatment. COPD, which comprises emphysema and chronic bronchitis, is a major public health problem and it is the fourth leading cause of death in the U.S. The study of the ADO index is published in the August 29 edition of the Lancet.
Results from a new major diabetes eye health study may have the potential to change the way vision loss due to diabetic macular edema, a serious and devastating complication of diabetes, is treated. One year results from the RESTORE study show that 37 per cent of patients treated with ranibizumab only and 43 per cent of those treated with ranibizumab plus laser therapy, had a significant improvement in visual acuity of 10 letters or more on an eye chart, compared to 16 per cent of patients treated with laser alone - the current standard treatment for visual impairment due to DME.
› Verified 4 days ago
Mrs. Yelena Nicolaevna Courchene, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 3 Mound Ct, Merrimack, NH 03054 Phone: 603-424-8866 Fax: 833-944-2252 | |
Mollie Claire Gardner, Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 5 Windsor Dr, Merrimack, NH 03054 Phone: 603-341-3499 | |
Mrs. Susan M Field, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 294 Daniel Webster Hwy, Merrimack, NH 03054 Phone: 606-440-7722 | |
Mrs. Laura Moll, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 696 Daniel Webster Hwy, Merrimack, NH 03054 Phone: 603-429-3155 | |
Karissa N Fox Koscheski, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 2 Dobson Way, Merrimack, NH 03054 Phone: 603-471-6069 Fax: 603-471-6068 | |
Jaime-lea Brenna Meyer, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 696 Daniel Webster Hwy, Merrimack, NH 03054 Phone: 603-429-3155 Fax: 603-424-8693 | |
Melanie V Chhoeun, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 2 Dobson Way, Merrimack, NH 03054 Phone: 603-471-6069 Fax: 603-471-6068 |